EUVIMEDEUVIMED entdecken
Crossref

Comprehensive Genomic Profiling of Indian Patients With Lung Cancer

Shivani Sharma, Vanita Noronha iD, Arti Yadav, Madhvi Mandhania, Sambit K Mohanty, Rahul Katara, Aditi Aggarwal, Sagar Samrat Mohanty iD, Akash Kumar, Sanjeev Kumar, Vipin Kumar, Kanika Jaggi und 7 weitere

JCO Global Oncology · 2025-05 · (11)

DOI: 10.1200/go-24-00587 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, 2025-05. Verfasst von Shivani Sharma und 18 weiteren Autor:innen. Beteiligte Einrichtung: CORE Diagnostics, Gurugram, India. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Genomic profiling has revolutionized non–small cell lung cancer (NSCLC) therapy, but molecular data on Indian patients with NSCLC are limited. MATERIALS AND METHODS We analyzed next-generation sequencing (NGS) data of 5,219 Indian patients with lung cancer, tested between May 2022 and August 2023 at CORE Diagnostics, a commercial laboratory in India. Using the PulmoCORE gene panel, we targeted 13 key genes ( ALK , BRAF , EGFR , ERBB2 , KRAS , MAP2K1 , MET , NRAS , PIK3CA , RET , ROS1 , TP53 , and NTRK ) for DNA and RNA sequencing. PD-L1 was tested by immunohistochemistry. RESULTS Median patient age was 62 years, and 62.5% were male. Common histologies included adenocarcinoma (57.1%), NSCLC not otherwise specified (19.3%), and squamous cell carcinoma (7%). Genomic alterations were detected in 80.6% patients according to the PulmoCORE panel; 64.2% patients had actionable alterations in at least one of the nine biomarkers with Food and Drug Administration–approved targeted therapies, that is, EGFR , KRAS , ALK , ROS1 , BRAF , NTRK1/2/3 , MET , RET , and ERBB2 . Common alterations included TP53 (37%), EGFR (34.1%), and KRAS (13.3%), ALK (8.8%), and others below 5%. Alterations were more common in adenocarcinoma (76.4%) than in patients with squamous cell carcinoma (29.9%). Sex and age influenced mutation prevalence, with EGFR mutations more common in females and KRAS in males, while ALK , ROS1 , and RET fusions were prevalent in younger adults. Most genomic alterations were mutually exclusive, although 25% patients had co-occurring mutations. PD-L1 positivity was higher in males (28.3%) and more common in patients with squamous cell carcinoma (34.2%). CONCLUSION Broad molecular profiling is important to detect actionable alterations in Indian patients with lung cancer, for delivering optimal personalized precision medicine. Our study underscores the fact that NGS should be routinely done before planning therapy in Indian patients with advanced lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungHumansMaleFemaleMiddle AgedIndiaAgedAdultHigh-Throughput Nucleotide SequencingAged, 80 and overBiomarkers, TumorGenomicsMutation

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • CORE Diagnostics, Gurugram, India.
  • Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai, India.
  • Section of Biostatistics, Center for Cancer Epidemiology, Tata Memorial Center, Homi Bhabha National Institute (HBNI), Mumbai, India.

ORCID-Profile: Vanita Noronha, Sagar Samrat Mohanty, Akash Pawar, Nandini Menon, Minit Shah, Kumar Prabhash

Zitieren

APA

Sharma, S., Noronha, V., Yadav, A., Mandhania, M., Mohanty, S. K., Katara, R., Aggarwal, A., Mohanty, S. S., Kumar, A., Kumar, S., Kumar, V., Jaggi, K., Sharma, D. K., Kumar, S., Apoorva, V., Pawar, A., Menon, N., Shah, M., & Prabhash, K. (2025). Comprehensive Genomic Profiling of Indian Patients With Lung Cancer. JCO Global Oncology. https://doi.org/10.1200/go-24-00587

Vancouver

Sharma S, Noronha V, Yadav A, Mandhania M, Mohanty SK, Katara R, et al. Comprehensive Genomic Profiling of Indian Patients With Lung Cancer. JCO Global Oncology. 2025. doi:10.1200/go-24-00587

BibTeX
@article{Sharma2025,
  author = {Sharma, Shivani and Noronha, Vanita and Yadav, Arti and Mandhania, Madhvi and Mohanty, Sambit K and Katara, Rahul and Aggarwal, Aditi and Mohanty, Sagar Samrat and Kumar, Akash and Kumar, Sanjeev and Kumar, Vipin and Jaggi, Kanika and Sharma, Deepak Kumar and Kumar, Sanjay and Apoorva, Vaishalee and Pawar, Akash and Menon, Nandini and Shah, Minit and Prabhash, Kumar},
  title = {Comprehensive Genomic Profiling of Indian Patients With Lung Cancer},
  journal = {JCO Global Oncology},
  year = {2025},
  number = {11},
  doi = {10.1200/go-24-00587}
}
Kostenlos starten →